65 I B, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79724D0191
- Awardee
-
Vanda Pharmaceuticals Inc. UEI NG5JU1TQ3379
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 1
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 43% complete
- IDV ceiling
- $16,131,060.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
GSA awarded a Federal Supply Schedule contract to Vanda Pharmaceuticals Inc. under the Pharmaceuticals and Drugs schedule (FSS-61-IB) on September 1, 2024, with a ceiling value of $16,131,060 and performance through August 31, 2029. The schedule is a multiple-award vehicle enabling federal agencies to place orders against Vanda's approved price list without conducting separate competitions.
Vanda holds approval under FSS-61-IB for drugs, pharmaceuticals, and hematology-related products classified as commercial items. The contract carries no set-aside designation. Place of performance is nationwide and worldwide, consistent with GSA Schedule scope. The Veterans Integrated Service Network 12 is the funding federal agency.
Recent ordering activity under this Schedule includes a delivery order issued by Veterans Integrated Service Network 20 on October 1, 2025, for $26,343.76 for HETLIOZ (tasimelteon) pharmaceutical products, with performance in Bartlett, Tennessee and completion by September 30, 2026. Vanda's primary federal offering under this vehicle is HETLIOZ, a specialized pharmaceutical product used to treat Non-24-Hour Sleep-Wake Disorder in blind adults and patients with Smith-Magenis Syndrome. The company also holds a single-award blanket purchase agreement under the same FSS-61-IB schedule with a ceiling of $3,753,465 through September 5, 2027.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Pharm - hetlioz | Veterans Integrated Service Network 20 (VHA) | $26,344 |
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79724A0032 | National Acquisition Center (VA) | $3,753,465 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36F79724D0191?
36F79724D0191 was awarded to Vanda Pharmaceuticals Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 1, 2024.
How much is contract 36F79724D0191 worth?
36F79724D0191's own ceiling is $16,131,060.
How many orders have been placed under contract 36F79724D0191?
1 order has been placed under 36F79724D0191, the latest on October 1, 2025.
Who can order from contract 36F79724D0191?
36F79724D0191 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79724D0191 part of a contract vehicle?
Yes. 36F79724D0191 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79724D0191 competed?
The extent of competition for 36F79724D0191 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV